In This Issue
I. Industrial Policy
Stipulation on Biological Product Comes Out
China Decides to Reinforce the Ephedrine Management
SDA Issued the Regulation on Sales Chain Enterprises
SDA Restate the Regulation on the foundation of Pharmaceutical Enterprise
Reform in Medicine Distribution
20 Pharm. Projects Prohibited
Development Priority of Phamaceutical Industry
II. News
Production Technology of D-hydroxyphenylglycine Broke Through in China
The Largest Deal of Biochip in China
The Largest Dihydrophenylglycine Salt Production Line in China
The largest Biological Engineering Production Base in Shenzhen
Shanghai Plant Gene Research Center Set up
EPO Will be Produced in Shenzhen
Lukang Makes Benzoic Acid from the Debris of 6APA
Chongqing BioPharmacetuical Garden Formed
Protein Peptide Research & Production Base to be Built in Wuhan
SDA Forbids the Illegal Approval of Drug
Provisional Regulation on Sildenalfil Citrate
United Gene Begin to Produce Gene Chip
Sanjiu Biochem Set up Gene Engineering Base in Shanghai
Pharmaceutical Price Greatly Lowered
The First Agricultural Hormane Center Found
DNA Cell Project Started up
Cell Engineering Center Found
D-p-hydroxybenzoglycid Potassium Production Began
D-p-hydroxybenzoglycin Research Succeeded
Tianjin Pharmaceutical Science & Technology Insitute is to Set up
Antibiotics Price Went up in first half 2000
State Basic Reimburseemtn Catalogue of Medicine Published
China is Ready to Product Loratidine
China Highlights the Guidance for Medicine Industry